Atherosclerosis is aggravated by iron overload and ameliorated by dietary and pharmacological iron restriction
- PMID: 30903157
- DOI: 10.1093/eurheartj/ehz112
Atherosclerosis is aggravated by iron overload and ameliorated by dietary and pharmacological iron restriction
Abstract
Aims: Whether and how iron affects the progression of atherosclerosis remains highly debated. Here, we investigate susceptibility to atherosclerosis in a mouse model (ApoE-/- FPNwt/C326S), which develops the disease in the context of elevated non-transferrin bound serum iron (NTBI).
Methods and results: Compared with normo-ferremic ApoE-/- mice, atherosclerosis is profoundly aggravated in iron-loaded ApoE-/- FPNwt/C326S mice, suggesting a pro-atherogenic role for iron. Iron heavily deposits in the arterial media layer, which correlates with plaque formation, vascular oxidative stress and dysfunction. Atherosclerosis is exacerbated by iron-triggered lipid profile alterations, vascular permeabilization, sustained endothelial activation, elevated pro-atherogenic inflammatory mediators, and reduced nitric oxide availability. NTBI causes iron overload, induces reactive oxygen species production and apoptosis in cultured vascular cells, and stimulates massive MCP-1-mediated monocyte recruitment, well-established mechanisms contributing to atherosclerosis. NTBI-mediated toxicity is prevented by transferrin- or chelator-mediated iron scavenging. Consistently, a low-iron diet and iron chelation therapy strongly improved the course of the disease in ApoE-/- FPNwt/C326S mice. Our results are corroborated by analyses of serum samples of haemochromatosis patients, which show an inverse correlation between the degree of iron depletion and hallmarks of endothelial dysfunction and inflammation.
Conclusion: Our data demonstrate that NTBI-triggered iron overload aggravates atherosclerosis and unravel a causal link between NTBI and the progression of atherosclerotic lesions. Our findings support clinical applications of iron restriction in iron-loaded individuals to counteract iron-aggravated vascular dysfunction and atherosclerosis.
Keywords: Atherosclerosis; Iron overload; Iron restriction; Non-transferrin bound iron (NTBI); Oxidative stress; Vascular iron deposition.
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.
Comment in
-
Iron and atherosclerosis: too much of a good thing can be bad.Eur Heart J. 2020 Jul 21;41(28):2696-2698. doi: 10.1093/eurheartj/ehz506. Eur Heart J. 2020. PMID: 31324916 No abstract available.
-
Vascular smooth muscle cell dysfunction in patients with hemochromatosis.Intern Emerg Med. 2023 Jan;18(1):311-313. doi: 10.1007/s11739-022-03127-1. Epub 2022 Oct 14. Intern Emerg Med. 2023. PMID: 36241935 No abstract available.
Similar articles
-
Chronic iron overload intensifies atherosclerosis in apolipoprotein E deficient mice: Role of oxidative stress and endothelial dysfunction.Life Sci. 2019 Sep 15;233:116702. doi: 10.1016/j.lfs.2019.116702. Epub 2019 Jul 26. Life Sci. 2019. PMID: 31356905
-
Iron and Atherosclerosis: The Link Revisited.Trends Mol Med. 2019 Aug;25(8):659-661. doi: 10.1016/j.molmed.2019.05.012. Epub 2019 Jun 20. Trends Mol Med. 2019. PMID: 31230908 Review.
-
Non-Transferrin-Bound Iron in the Spotlight: Novel Mechanistic Insights into the Vasculotoxic and Atherosclerotic Effect of Iron.Antioxid Redox Signal. 2021 Aug 20;35(6):387-414. doi: 10.1089/ars.2020.8167. Epub 2021 Mar 22. Antioxid Redox Signal. 2021. PMID: 33554718 Free PMC article. Review.
-
Analytical evaluation of serum non-transferrin-bound iron and its relationships with oxidative stress and cardiac load in the general population.Medicine (Baltimore). 2021 Feb 19;100(7):e24722. doi: 10.1097/MD.0000000000024722. Medicine (Baltimore). 2021. PMID: 33607814 Free PMC article.
-
Plasma non-transferrin-bound iron uptake by the small intestine leads to intestinal injury and intestinal flora dysbiosis in an iron overload mouse model and Caco-2 cells.Sci China Life Sci. 2023 Sep;66(9):2041-2055. doi: 10.1007/s11427-022-2347-0. Epub 2023 Jul 11. Sci China Life Sci. 2023. PMID: 37452897
Cited by
-
Ferroptosis of Endothelial Cells in Vascular Diseases.Nutrients. 2022 Oct 26;14(21):4506. doi: 10.3390/nu14214506. Nutrients. 2022. PMID: 36364768 Free PMC article. Review.
-
The role of iron metabolism in chronic diseases related to obesity.Mol Med. 2022 Nov 5;28(1):130. doi: 10.1186/s10020-022-00558-6. Mol Med. 2022. PMID: 36335331 Free PMC article. Review.
-
The role of ferroptosis in intervertebral disc degeneration.Front Cell Dev Biol. 2023 Jul 27;11:1219840. doi: 10.3389/fcell.2023.1219840. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37576601 Free PMC article. Review.
-
Autophagy, Pyroptosis, and Ferroptosis: New Regulatory Mechanisms for Atherosclerosis.Front Cell Dev Biol. 2022 Jan 13;9:809955. doi: 10.3389/fcell.2021.809955. eCollection 2021. Front Cell Dev Biol. 2022. PMID: 35096837 Free PMC article. Review.
-
Potential intervention target of atherosclerosis: Ferroptosis (Review).Mol Med Rep. 2022 Nov;26(5):343. doi: 10.3892/mmr.2022.12859. Epub 2022 Sep 23. Mol Med Rep. 2022. PMID: 36148885 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
